期刊文献+

Ph^+急性淋巴细胞白血病与慢性粒细胞白血病急淋变的比较研究 被引量:3

Comparative clinical study of Philadelphia chromosome-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myelogenous leukemia
原文传递
导出
摘要 目的探讨Ph染色体阳性急性淋巴细胞白血病(Ph+ALL)与慢性粒细胞白血病急淋变的临床特点。方法对21例Ph+ALL患者及31例慢粒急淋变患者的临床资料进行回顾性对比分析。结果 Ph+ALL与慢粒急淋变有以下区别:①慢粒急淋变肝脾肿大发生率(80.65%)比Ph+ALL(14.28%)高(P<0.05);②起病时慢粒急淋变外周血白细胞数比Ph+ALL高(P<0.05);③Ph+ALL完全缓解率(76.19%)比慢粒急淋变(48.39%)高(P<0.05)。Ph+ALL的中位生存期为(10.76±6.91)个月,而慢粒急淋变的中位生存期为(7.06±6.03)个月,差异有统计学意义(P<0.05)。慢粒急淋变者完全缓解后Ph染色体持续存在,Ph+ALL患者完全缓解后Ph染色体消失。两组患者年龄、性别、骨髓中原始加幼稚细胞数差异均无统计学意义(P>0.05)。结论 Ph+ALL与慢粒急淋变具有不同的临床特点及治疗反应。 Objective To explore the clinical features of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia(Ph+ALL) and with chronic myeloid leukemia in lymphoid blast crisis(CML LBC).Methods Retrospective analysis of the clinical data of 21 cases of Ph+ALL and 31 cases of CML LBC.Results Comparing with Ph+ALL patients,CML LBC patients showed following clinical features: ① The incidence of splenomegaly and hepatomegaly(80.65%)was higher than that of Ph+ALL(14.28%)(P0.05).② The white blood cell count was higher than that of Ph+ALL(P0.05).③ The complete remission rate(CR)(48.39%) was lower than that of Ph+ALL(76.19%)(P0.05).The median survival time of patients with Ph+ALL was(10.76±6.91) months,which was significantly longer than that of CML LBC(7.06±6.03)months,(P0.05).Philadelphia chromosome was still present in bone marrow cells after patients with CML LBC reached complete remission,but it was negative in patients with Ph+ALL.There was no significant differences between the two groups with regard to age,sex,the bone marrow progenitor cells and immature cells(P0.05).Conclusions Paitents with Ph+ALL and CML LBC present with different clinical features and therapeutic response.
出处 《医药论坛杂志》 2012年第1期23-25,28,共4页 Journal of Medical Forum
关键词 PH染色体 急性淋巴细胞白血病 慢性粒细胞白血病 急淋变 Philadelphia chromosome Acute lymphoblastic leukemia Chronic myeloid leukemia Lymphoid blast crisis
  • 相关文献

参考文献2

二级参考文献24

  • 1Elaine S, Harris N, Stein H. Pathology and genetics of tumors of haematopietic and lymphoid tissues. France: IARC Press International Agency for Research on Cancer (IARC)69008 Lyon, France. 2001:76.
  • 2Udayakumar AM, Pathare AV, Al-Kindi S, et al. Cytogenetic, morphological and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia. Cancer Genet Cytogenet, 2007;177: 89 - 94.
  • 3Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev, 2004; 18:115 -156.
  • 4King ME, Rowe JM. Recent developments in acute myelogenous leukemia therapy. Oncologist, 2007 ; 12 ( Suppl 2 ) : 14 - 21.
  • 5Shaffer LG, Tommerup N. ISCN ( 2005 ). An International System for Human Cytogenetic Nomenclature. Switzerland: Karger Basel publication, 2005:55 - 83.
  • 6Onsten T, Girardi FM, Coelho GM, et al. Cytogenetic and morphological findings in 166 patients with de novo acute myeloid leukemia in southern. Brazil Cancer Genet Cytogenet, 2006 ; 170 : 167 - 170.
  • 7Klaus M, Haferlaeh T, Sehnittger S, et al. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1 and M2 : a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cytogenet, 2004; 155:47-56.
  • 8Litmanovich D, Zamir-Brill R, Jeison M, et al. Is inversion 16 a prerequisite and id trisomy 22 invariably associated with inversion 16 in AML-M4eo? Cancer Genet Cytogenet, 2000 ; 121 : 106.
  • 9Udayakumar AM, Pathare AV, Al-Kindi S,et al. Cytogenetic, morphological and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia. Cancer Genet Cytogenet. 2007 ; 177 : 89 - 94.
  • 10Nowell P, Hungerford DA. A minute chromosome in human granulocytic leukemia. Science. 1960 ; 132 : 1497 - 1501.

共引文献41

同被引文献25

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部